Get care your way with: Consultations may be available in-office in Hollywood, Florida , or through telehealth for eligible Florida residents when clinically appropriate
Users generally inject it subcutaneously (e.g
This formulation delivers a unique preparation of glutathione that overcomes these usual limitations
Key facts SKU: ALP-IGF Form: Lyophilised powder Presentation: Mass per vial as selected on the product page Appearance (typical): White to off-white lyophilised powder Intended laboratory context Controlled in-vitro models where IGF-axis biology is studied under institutional protocols Analytical characterisation and method development Non-clinical peptide handling and preparation workflows in laboratory settings Specifications Batch identity and purity parameters appear on the COA where stated for the lot supplied Handle as potent laboratory peptide per SDS Documentation scope may be limited to in-house or supplier release records for some lots (see notice in short description) Documentation and batch release COA and SDS are supplied with released lots within the scope described on this page
T1DM is associated with decreased IGF-1 levels, GH, and IGFBP-1
Vegetarian status unknown Unrecognized ingredients: reduced-glutathione, ubiquinone, pqq, alpha-lipoic-acid, phosphatidylcholine, orange essential oil Some ingredients could not be recognized
